Table 3.
Adverse events reported by both adult and paediatric patients (percent with symptom) on admission (day 0) and during the whole of the 28-day follow-up period
| Patients with symptom (%) | ||
|---|---|---|
| Symptom | Day 0 (n = 85) | Post-treatment (n = 83)1 |
| Headache | 55% | 36% |
| Dizziness | 24% | 14% |
| Abdominal pain | 12% | 11% |
| Anorexia | 15% | 1% |
| Nausea | 14% | 4% |
| Tinnitus | 8% | 6% |
| Deafness | 5% | 2% |
| Palpitations | 0% | 1% |
| Insomnia | 2% | 1% |
Two patients lost to follow-up.